Cancer Study

Michael Rodio | Oct. 31, 2013 | Harper Cancer Research Institute

Jenifer ProsperiDr. Jenifer Prosperi

Over the past 15 years, the scientific community has come to understand that breast cancer is a monster with many faces.

Some cancers have one of three special indicator molecules (HER2, estrogen receptors and progesterone receptors) that can guide targeted anti-cancer treatments. But another set of breast cancers, the “triple-negative” types, lack those three indicator molecules that can guide treatment. And even now, the question remains: How can doctors better target and treat triple-negative cancers? And how can they keep up the treatment when breast cancers fight back?

Here, in this poorly-mapped corner of breast cancer research, Dr. Jenifer Prosperi is trying to answer both questions by looking in one place.

Read more at the Harper Cancer Research Institute

 by Daily Domer Staff

Posted In: Spotlights